Literature DB >> 32060787

Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases.

Amber Cintosun1, Irene Lara-Corrales2, Elena Pope3.   

Abstract

The legalisation of cannabis in a growing number of jurisdictions has led to increasing interest in its potential therapeutic effects in a range of disorders, including cutaneous conditions. Cannabinoids have been used as natural medicines for centuries; however, their biological activity in the skin is a new area of study. Recent data suggest that cannabinoids are involved in neuro-immuno-endocrine modulation of skin functioning, yet their effect on the features of dermatologic conditions is unclear. This article sought to review the mechanisms by which cannabinoids regulate skin functioning through the lens of relevance to treatment of dermatologic diseases looking at the effects of cannabinoids on a range of cellular activities and dermatologic conditions both in vitro and in vivo. We identified studies demonstrating an inhibitory effect of cannabinoids on skin inflammation, proliferation, fibrosis, pain, and itch-biological mechanisms involved in the pathogenesis of many dermatologic conditions. Cannabinoids have the potential to expand the therapeutic repertoire of a wide spectrum of skin disorders. Given their widespread unregulated use by the general public, basic and clinical studies are required to elucidate the effectiveness and long-term effects of topical and systemic cannabinoids in cutaneous disorders.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32060787     DOI: 10.1007/s40261-020-00894-7

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  78 in total

1.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

Review 2.  New approaches and challenges to targeting the endocannabinoid system.

Authors:  Vincenzo Di Marzo
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

3.  Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis?

Authors:  Estrella Garcia-Gonzalez; Mauro Galeazzi; Enrico Selvi
Journal:  Isr Med Assoc J       Date:  2016 Mar-Apr       Impact factor: 0.892

4.  The trajectories of cannabis and tobacco policies in the United States, Uruguay, Canada and Portugal: is more cross-substance learning possible outside the United States?

Authors:  Caitlin Elizabeth Hughes
Journal:  Addiction       Date:  2017-08-23       Impact factor: 6.526

Review 5.  Cannabinoid system in the skin - a possible target for future therapies in dermatology.

Authors:  Piotr Kupczyk; Adam Reich; Jacek C Szepietowski
Journal:  Exp Dermatol       Date:  2009-08       Impact factor: 3.960

Review 6.  The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.

Authors:  Tamás Bíró; Balázs I Tóth; György Haskó; Ralf Paus; Pál Pacher
Journal:  Trends Pharmacol Sci       Date:  2009-07-14       Impact factor: 14.819

Review 7.  Pain and pain management in dermatology.

Authors:  Ulrike Beiteke; Stefan Bigge; Christina Reichenberger; Ingrid Gralow
Journal:  J Dtsch Dermatol Ges       Date:  2015-10       Impact factor: 5.584

8.  Attenuation of allergic contact dermatitis through the endocannabinoid system.

Authors:  Meliha Karsak; Evelyn Gaffal; Rahul Date; Lihua Wang-Eckhardt; Jennifer Rehnelt; Stefania Petrosino; Katarzyna Starowicz; Regina Steuder; Eberhard Schlicker; Benjamin Cravatt; Raphael Mechoulam; Reinhard Buettner; Sabine Werner; Vincenzo Di Marzo; Thomas Tüting; Andreas Zimmer
Journal:  Science       Date:  2007-06-08       Impact factor: 47.728

Review 9.  Cannabis: A Treasure Trove or Pandora's Box?

Authors:  Katalin Solymosi; Attila Köfalvi
Journal:  Mini Rev Med Chem       Date:  2017       Impact factor: 3.862

Review 10.  Endocannabinoid signaling at the periphery: 50 years after THC.

Authors:  Mauro Maccarrone; Itai Bab; Tamás Bíró; Guy A Cabral; Sudhansu K Dey; Vincenzo Di Marzo; Justin C Konje; George Kunos; Raphael Mechoulam; Pal Pacher; Keith A Sharkey; Andreas Zimmer
Journal:  Trends Pharmacol Sci       Date:  2015-03-18       Impact factor: 14.819

View more
  5 in total

Review 1.  Cannabinoids for Symptom Management in Patients with Kidney Failure: A Narrative Review.

Authors:  Hayley Worth; Daniel V O'Hara; Neeru Agarwal; David Collister; Frank Brennan; Brendan Smyth
Journal:  Clin J Am Soc Nephrol       Date:  2022-01-05       Impact factor: 10.614

Review 2.  Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review.

Authors:  Ana M Martins; Ana L Gomes; Inês Vilas Boas; Joana Marto; Helena M Ribeiro
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-09

3.  Medical cannabis dimethyl ether, ethanol and butane extracts inhibit the in vitro growth of bacteria and dermatophytes causing common skin diseases.

Authors:  Tomáš Skala; Zdeˇnka Kahánková; Jan Tauchen; Anežka Janatová; Pavel Klouˇcek; Vít Hubka; Adéla Fraˇnková
Journal:  Front Microbiol       Date:  2022-09-20       Impact factor: 6.064

Review 4.  Comparative effects of capsaicin in chronic obstructive pulmonary disease and asthma (Review).

Authors:  Mihai-Daniel Dumitrache; Ana Stefania Jieanu; Cristian Scheau; Ioana Anca Badarau; George Denis Alexandru Popescu; Ana Caruntu; Daniel Octavian Costache; Raluca Simona Costache; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

Review 5.  Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier.

Authors:  Cristian Scheau; Constantin Caruntu; Ioana Anca Badarau; Andreea-Elena Scheau; Anca Oana Docea; Daniela Calina; Ana Caruntu
Journal:  J Pers Med       Date:  2021-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.